Japan initially struggled to get the covid vaccination program into full equipment, but now has, the percentage of the population has received at least one dose has risen through the level achieved in the US – leaving Americans among these categories among the world seven richest democracies.
The turning point occurred on Thursday, when our world in the data, a project by the University of Oxford in the UK, reported that more than 62.1% of Japanese were at least a partial vaccinated, compared to 61.9% of Americans.
For now, the US maintains a slightly larger percentage of people who are fully vaccinated than Japan, 52.7% compared to more than 50%, according to our world in the data, the sixth rank of the G7 nations, after England, Canada , France, Germany and Italy.
But the US seems to be all but surely falls into the last place among the G7 nations immediately, given the fast rate to achieve full vaccination in Japan and a very slow level in the US.
Between July 24 and September 9, the full level of vaccination in the US grew by around 4%, while in the same period Japan lifted its level by 25%, the leap doubled the size of a population that was fully vaccinated.
Using the dosage made by Pfizer, Modera and AstraZeneca, Japan provides more than one million doses of vaccines per day, around 300,000 above the US average, even though the US population is more than 2.6 times the size of Japan.
In Japan, new cases have fallen sharply from the peak of 23,083 on August 25, 11,347 on Friday, although Japan faced a dramatic increase in new cases in July and August, to coincide with the Olympics.
In the US, spiked cases began in early July.
Canada leads the G7 countries at the vaccination rate, with almost three quarters of the population at least some vaccinated on Thursday, according to our world in the data.
France, Italy and England follow, with a percentage between 70 and 73.
German rates right in front of Japan, around 65%.
The US vaccination curve has been dramatically flattened since the initial surge in the first half of this year, when the vaccine is widely available.